sunitinib/mylan 37.5mg/cap καψακιο, σκληρο
mylan ireland limited, ireland (0000013255) unit 35/36 grange parade, dublin 13, - - sunitinib - ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ - 37.5mg/cap - 0557795194 sunitinib 37.500000 mg - sunitinib
sunitinib/mylan 50mg/cap καψακιο, σκληρο
mylan ireland limited, ireland (0000013255) unit 35/36 grange parade, dublin 13, - - sunitinib - ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ - 50mg/cap - 0557795194 sunitinib 50.000000 mg - sunitinib
sunitinib/mylan 25mg/cap καψακιο, σκληρο
mylan ireland limited, ireland (0000013255) unit 35/36 grange parade, dublin 13, - - sunitinib - ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ - 25mg/cap - 0557795194 sunitinib 25.000000 mg - sunitinib
sunitinib/mylan 12.5mg/cap καψακιο, σκληρο
mylan ireland limited, ireland (0000013255) unit 35/36 grange parade, dublin 13, - - sunitinib - ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ - 12.5mg/cap - 0557795194 sunitinib 12.500000 mg - sunitinib
sunitinib/sandoz 37.5mg/cap καψακιο, σκληρο
sandoz pharmaceuticals d.d. (abbr. sandoz d.d.), slovenia (0000011016) verovskova 57, ljubljana, si-1000 - sunitinib - ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ - 37.5mg/cap - 0557795194 sunitinib 37.500000 mg - sunitinib
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Αντινεοπλασματικοί παράγοντες - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib pharmascience 37.5mg capsule,hard
pharmascience international ltd (0000011496) lampousas 1, nicosia, 1095 - sunitinib hydrochloride - capsule,hard - 37.5mg - sunitinib hydrochloride (0873077704) 40,939mg
sunitinib pharmascience 25mg capsule,hard
pharmascience international ltd (0000011496) lampousas 1, nicosia, 1095 - sunitinib hydrochloride - capsule,hard - 25mg - sunitinib hydrochloride (0873077704) 27,293mg
sunitinib pharmascience 12.5mg capsule,hard
pharmascience international ltd (0000011496) lampousas 1, nicosia, 1095 - sunitinib hydrochloride - capsule,hard - 12.5mg - sunitinib hydrochloride (0873077704) 13,646mg
sunitinib pharmascience 50mg capsule,hard
pharmascience international ltd (0000011496) lampousas 1, nicosia, 1095 - sunitinib hydrochloride - capsule,hard - 50mg - sunitinib hydrochloride (0873077704) 54,585mg